Exploring new biological treatments in posterior uveitis
Quan Dong Nguyen, MD, MSc, FARVO, FASRS, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.
Video Player is loading.
Quan Dong Nguyen, MD, MSc, FARVO, FASRS, director of the Uveitis and Ocular Inflammation Service, Byers Eye Institute, Stanford University School of Medicine, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.
Recent Videos
Snowmass Retina & Eye 2025: Ronald Frenkel, MD, previews the unique agenda with a fusion of retina, cataract, and glaucoma
WIO 2024: An educator's perspective on shattering glass ceilings in ophthalmology
WIO 2024: Integrating AI for postoperative patient care
ARVO 2024: What retinal specialists can learn about DRIL from the POINT study
ARVO 2024: Extended treatment outcomes and the potential for Q20W dosing with faricimab in nAMD
COPHy 2024: Should all patients with idiopathic intracranial hypertension have a lumbar puncture?
ASRS 2023: Attendees share the topics from the annual meeting that interest them
ASRS 2023: Our team asked interviewees which presentations at the annual ASRS meeting they find most interesting
ASRS 2023: Which topics at the annual meeting did researchers find exciting?
ASRS 2023: What research is most exciting? Our interviewees weigh in.
Related Content
